Trials / Completed
CompletedNCT00831259
Risk of Stroke in Pulmonary Embolism With a Patent Foramen Ovale (PFO)
Silent Cerebral Infarcts in Patients With Pulmonary Embolism and a Patent Foramen Ovale: a Prospective Diffusion-weighted Magnetic Resonance Imaging Study.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (estimated)
- Sponsor
- University Hospital, Caen · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Pulmonary embolism is associated with a small but definite risk of paradoxical embolism in patients with a patent foramen ovale (PFO). While neurologic complications are unfrequent the incidence of clinically silent brain infarction is unknown. We will assess the rate of clinically apparent and silent cerebral embolism in patients with a pulmonary embolism (PE) in relation to the presence or not of a PFO.
Conditions
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2009-04-01
- Completion
- 2009-05-01
- First posted
- 2009-01-28
- Last updated
- 2011-05-20
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00831259. Inclusion in this directory is not an endorsement.